Understanding the role of the death receptor 5/FADD/caspase-8 death signaling in cancer metastasis

Molecular and Cellular Pharmacology

Volumn 3, Issue 1, 2011, Pages 31-34

  Sun, Shi Yong ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caspase 8; DR5; FADD; Fas; Metastasis

Indexed keywords

CASPASE 8; DEATH RECEPTOR 5; FAS ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANOIKIS; APOPTOSIS; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NONHUMAN; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

EID: 79952240840     PISSN: None     EISSN: 19381247     Source Type: Journal    
DOI: 10.4255/mcpharmacol.11.05     Document Type: Review

References (36)

1. Elrod HA, Fan S, Muller S et al. Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact. PLoS One 2010;5:e12178.
2. Elrod HA, Sun SY. Modulation of death receptors by cancer therapeutic agents. Cancer Biol Ther 2007;7:163-73.
3. Ashkenazi A. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev 2008;19:325-31.
4. Roth W, Reed JC. FLIP protein and TRAIL-induced apoptosis. Vitam Horm 2004;67:189-206.
5. Wajant H. Targeting the FLICE Inhibitory Protein (FLIP) in cancer therapy. Mol Interv 2003;3:124-7.
6. Eccles SA, Welch DR. Metastasis: recent discoveries and novel treatment strategies. Lancet 2007;369:1742-57.
7. Mehlen P, Puisieux A. Metastasis. a question of life or death. Nat Rev Cancer 2006;6:449-58.
8. Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis. Cancer Lett 2008; 272:177-85.
9. Chiarugi P, Giannoni E. Anoikis. a necessary death program for anchorage-dependent cells. Biochem Pharmacol 2008;76:1352-64.
10. Zhou XD, Yu JP, Liu J et al. Overexpression of cellular FLICE-inhibitory protein (FLIP) in gastric adenocarcinoma. Clin Sci (Lond) 2004;106:397-405.
11. Ullenhag GJ, Mukherjee A, Watson NF et al. Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients. Clin Cancer Res 2007;13:5070-5.
12. Jonsson G, Paulie S, Grandien A. High level of cFLIP correlates with resistance to death receptor-induced apoptosis in bladder carcinoma cells. Anticancer Res 2003;23:1213-8.
13. Zhang X, Jin TG, Yang H et al. Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer. Cancer Res 2004;64:7086-91.
14. Mawji IA, Simpson CD, Hurren R et al. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation. J Natl Cancer Inst 2007;99:811-22.
15. Wilson TR, McLaughlin KM, McEwan M et al. c-FLIP: a key regulator of colorectal cancer cell death. Cancer Res 2007;67:5754-62.
16. Siegmund D, Hadwiger P, Pfizenmaier K, Vornlocher HP, Wajant H. Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis. Mol Med 2002;8:725-32.
17. Sharp DA, Lawrence DA, Ashkenazi A. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J Biol Chem 2005;280:19401-9.
18. Wilson TR, Redmond KM, McLaughlin KM et al. Procaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing. Cell Death Differ 2009;16:1352-61.
19. Takeda K, Hayakawa Y, Smyth MJ et al. Involvement of tumor necrosis factorrelated apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 2001;7:94-100.
20. Smyth MJ, Cretney E, Takeda K et al. Tumor necrosis factor-related apoptosisinducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001;193:661-70.
21. Grosse-Wilde A, Voloshanenko O, Bailey SL et al. TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development. J Clin Invest 2008;118:100-10.
22. Zhuang L, Lee CS, Scolyer RA et al. Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosisinducing ligand. Hum Pathol 2006;37:1286-94.
23. Spierings DC, de Vries EG, Timens W et al. Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors. Clin Cancer Res 2003;9:3397-405.
24. Ganten TM, Sykora J, Koschny R et al. Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer. J Mol Med 2009;87:995-1007.
25. Macher-Goeppinger S, Aulmann S, Tagscherer KE et al. Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer. Clin Cancer Res 2009;15:650-9.
26. Trauzold A, Siegmund D, Schniewind B et al. TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma. Oncogene 2006;25:7434-9.
27. Hoogwater FJ, Nijkamp MW, Smakman N et al. Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells. Gastroenterology 2010; 138:2357-67.
28. Chen G, Bhojani MS, Heaford AC et al. Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc Natl Acad Sci U S A 2005;102:12507-12.
29. Stupack DG, Teitz T, Potter MD et al. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 2006;439:95-9.
30. Barbero S, Mielgo A, Torres V et al. Caspase-8 association with the focal adhesion complex promotes tumor cell migration and metastasis. Cancer Res 2009;69:3755-63.
31. Senft J, Helfer B, Frisch SM. Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. Cancer Res 2007;67:11505-9.
32. Finlay D, Vuori K. Novel noncatalytic role for caspase-8 in promoting SRC-mediated adhesion and Erk signaling in neuroblastoma cells. Cancer Res 2007;67:11704-11.
33. Helfer B, Boswell BC, Finlay D et al. Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions. Cancer Res 2006;66:4273-8.
34. Torres VA, Mielgo A, Barbero S et al. Rab5 mediates caspase-8-promoted cell motility and metastasis. Mol Biol Cell 2010;21:369-76.
35. Chen L, Park SM, Tumanov AV et al. CD95 promotes tumour growth. Nature 2010;465:492-6.
36. Kleber S, Sancho-Martinez I, Wiestler B et al. Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell 2008;13:235-48.